A Safety Study of LY3493269 Given as a Single Injection in Healthy Participants

NCT04178733 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3493269 - SC
DRUG: Placebo - SC
DRUG: LY3493269 - IV

Sponsor

Eli Lilly and Company